zementa 10 mg film-coated tablet film-coated tablet
spimaco, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg
zementa 20 mg film-coated tablet film-coated tablet
spimaco, saudi arabia - memantine hydrochloride - film-coated tablet - 20 mg
dement 10 mg film-coated tablet film-coated tablet
jazeera pharmaceutical industries (jpi), saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg
zementa 5 mg film-coated tablet
spimaco - memantine hydrochloride - film-coated tablet - 5 mg
memaxia 10 mg film-coated tablet film-coated tablet
jamjoom pharmaceuticals company, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg
memantine grindeks 10 mg
a.l. medi-market ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 10 mg - memantine - treatment of patient with moderate to severe alzheimer's disease.
tabixa 10mg film coated tablet
tabuk pharmaceutical manufacturing company, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg
ibuprofen tablet, film coated 600mg
accord healthcare limited - ibuprofen - film-coated tablet - ibuprofen 600 mg - antiinflammatory and antirheumatic products
memantine hydrochloride- memantine tablet, film coated
amneal pharmaceuticals of new york llc - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated populat
memantine sandoz 20mg film-coated tablets
1 a pharma gmbh - memantine hydrochloride 20 mg - film-coated tablet